Torsemide is a new generation of highly efficient myelin diuretics. It has been proven in more than 20 years of clinical application that torasemide has a wide range of indications. The diuretic effect is rapid, powerful and long-lasting. The incidence of adverse reactions is low. It is more in line with the requirements of pharmacoeconomics and is clinically relevant. A class of highly effective diuretics worthy of promotion.

Drug Name: Torsemide for Injection

Torsemide is a new generation of highly efficient myelin diuretics that was marketed in Germany in 1993 and listed in the United States the following year. More than 20 years of clinical application have confirmed that torasemide is widely used for indications, and its diuretic effect is rapid, powerful and long-lasting. The incidence of adverse reactions is low, and it is in line with the requirements of pharmacoeconomics. It is a class of highly effective diuretics that are worthy of promotion in clinical practice.

Its molecular formula is C16H20N4O3S and its molecular weight is 348.42CAS no 56211-40-6